Translational Development Acquisition Corp. (TDAC)

TDAC Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2024
Period Ending	Oct 10, 2025	Dec 31, 2024	Dec 31, 2023
Market Cap	229	219	219
Enterprise Value	228.68	218.86	219.64
Last Close Price	10.35	10.01	10.01
PE Ratio	75.31	-1001.00	-
PB Ratio	-	-39.18	-431.97
P/TBV Ratio	-	-0.59	-
P/FCF Ratio	-	-257.55	-1074970.96
P/OCF Ratio	-	-257.55	-1074970.96
EV/EBITDA Ratio	-	-1114.58	-452.35
EV/EBIT Ratio	-	-1114.58	-452.35
EV/FCF Ratio	-	-257.04	-1076664.48
Debt / Equity Ratio	0	0	-0.68
Debt / EBITDA Ratio	-	-	-0.72
Debt / FCF Ratio	-	-	-1703.43
Quick Ratio	625.47	831.13	0.00
Current Ratio	0.55	3.09	0.00
Return on Equity (ROE)	0.00%	2.33%	95.65%
Return on Assets (ROA)	0.00%	-0.22%	-24025.24%
Return on Capital (ROIC)	0.00%	-0.22%	-139.73%
Return on Capital Employed (ROCE)	0.00%	-0.23%	95.65%
Earnings Yield	1.33%	-0.10%	0.00%
FCF Yield	-	-0.39%	-0.00%
Buyback Yield / Dilution	0.00%	-80.31%	0.00%
Total Shareholder Return	-	-80.31%	0.00%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q